The prevalence of antibody to parvovirus B19 in hemophiliacs and in the general population

Zentralblatt fur Bakteriologie

Volumn 284, Issue 2-3, 1996, Pages 232-240

  Eis Hubinger A M ^a   Oldenburg, J ^a   Brackmann, H H ^a   Matz, B ^a   Schneweis, K E ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030199077     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(96)80098-3     Document Type: Article

References (48)

1. Anderson, M. J., S. E. Jones, S. P. Fisher-Hoch, E. Lewis, S. M. Hall, C. L. R. Bartlett, B. J. Cohen, P. P. Mortimer, and M. S. Pereira: Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 1378
2. Azzi, A., S. Ciappi, K. Zakvrzewska, M. Morfini, G. Mariani, and P. M. Mannucci: Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Amer. J. Hematol. 39 (1992) 228-230
3. Bartolomei Corsi, O., A. Azzi, M. Morfini, R. Fanci, and P. Rossi Ferrini: Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J. Med. Virol. 25 (1988) 165-170
4. von dem Borne, A. E. G. K., M. J. E. Bos, N. Joustra-Maas, J. F. Tromp, R. van Wijngaarden-Du Bois, and P. A. T. Tetteroo: A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br. J. Haematol. 63 (1986) 35-46
5. Brown, T., A. Anand, L. D. Ritchie, J. P. Clewley, and T. M. S. Reid: Intrauterine parvovirus infection associated with hydrops fetalis. Lancet (1984) 1033-1034
6. Brown, K. E., S. M. Anderson, and N. S. Young: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262 (1993) 114-117
7. Cassinotti, P., M. Weitz, and G. Siegl: Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay. J. Med. Virol. 40 (1993) 228-243
8. Cohen, B. J. and M. M. Buckley. The prevalence of antibody to human parvovirus B19 in England and Wales. J. Med. Microbiol. 25 (1988) 151-153
9. Cohen, B. J., A. M. Field, S. Gudnadottir, S. Beard, and J. A. J. Barbara: Blood donor screening for parvovirus B19. J. Virol. Methods 30 (1990) 233-238
10. Cohen, B., A. Millar, and P. Schwind: Screening blood donations for parvovirus B19. Lancet 346 (1995) 1631
11. Feldmann, R., M. Harms, and J.-H. Saurat: Papular-purpuric 'gloves and socks' syndrome: not only parvovirus B19. Dermat. 188 (1994) 85-87
12. Finkel, T. H., T. J. Török, P. J. Ferguson, E. L. Durigon, S. R. Zaki, D. Y. M. Leung, R. J. Harbeck, E. W. Gelfand, F. T. Saulsbury, J. R. Hollister, and L. J. Anderson: Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiologic agent? Lancet 343 (1994) 1255-1208
13. Foto, F., K. G. Saag, L. L. Scharosch, E. J. Howard, and S. J. Naides: Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J. Infect. Dis. 167 (1993) 744-748
14. Frickhofen, N. and N. S. Young: Persistent parvovirus B19 infections in humans. Microbial. Pathog. 7 (1989) 319-327
15. Gahr, M., A. Pekrun, and H. Eiffert: Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Eur. J. Pediatr. 150 (1991) 470-472
16. Gottlieb, F. and J. Deutsch: Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection. Amer. J. Med. 92 (1992) 331-333
17. Große-Bley, A., A. M. Eis-Hübinger, R. Kaiser, J. Oldenburg, H. H. Brackmann, T. F. Schwarz, and K. E. Schneweis: Serological and virological markers of human parvovirus B19 infection in sera of Hemophiliacs. Thromb. Haemost. 72 (1994) 503-507
18. Halasz, C. L., D. Cormier, and M. Den: Petechial glove and sock syndrome caused by parvovirus B19 J. Amer. Acad. Dermatol. 27 (1992) 835-838
19. Kerr, J. R., M. D. Curran, J. E. Moore, P. V. Coyle, and W. P. Ferguson: Persistent parvovirus B19 infection. Lancet 345 (1995) 1118
20. Knott, P. D., G. A. C. Welply, and M. J. Anderson: Serologically proved intrauterine infection with parvovirus. Br. Med. J. 289 (1984) 1660
21. Kurtzman, G. J., K. Ozawa, B. Cohen, G. Hanson, R. Oseas, and N. S. Young: Chronic bone marrow failure due to persistent B19 parvovirus infection. N. Engl. J. Med. 317 (1987) 287-294
22. Kurtzman, G., N. Frickhofen, J. Kimbali, D. W. Jenkins, A. W. Nienhuis, and N. S. Young: Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med. 321 (1989) 519-523
23. Lefrere, J.-J., M. Mariotti, and M. Thauvin: B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates. Lancet 343 (1994) 211-212
24. Lyon, D. J., C. S. Chapman, C. Martin, K. E. Brown, J. P. Clewley, A. J. E. Flower, and V. E. Mitchell: Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet (1989) 1085
25. Malm, C., E. Fridell, and K. Jansson: Heart failure after parvovirus B19 infection. Lancet 341 (1993) 1408-1409
26. McOmish, F., P. L. Yap, A. Jordan, H. Hart, B. J. Cohen, and P. Simmonds: Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J. Clin. Microbiol. 31 (1993) 323-328
27. Morfini, M., G. Longo, P. Rossi Ferrini, A. Azzi, C. Zakrewska, S. Ciappi, and P. Kolumban: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus. Amer. J. Hematol. 39 (1992) 149-150
28. Mortimer, P. P., N. L. C. Luban, J. F. Kelleher, and B. J. Cohen: Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet (1983) 482-484
29. Musiani, M., M. Zerbini, G. Gentilomi, G. Rodorigo, V. De Rosa, D. Gibellini, S. Venturoli, and G. Gallinella: Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients. J. Med. Virol. 46 (1995) 103-106
30. Naides, S. J., E. J. Howard, N. S. Swack, C. A. True, and J. T. Stapleton: Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy. J. Infect. Dis. 168 (1993) 101-105
31. Pattison, J. R., S. E. Jones, J. Hodgson, E. R. Davis, J. M. White, C. E. Stroud, and L. Murtaza: Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 664-665
32. Reid, D. M., T. Brown, T. M. S. Reid, J. A. N. Rennie, and C. J. Eastmond: Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet (1985) 422-425
33. Rollag, H., G. Patou, J. Pattison, M. Degre, S. A. Evensen, S. S. Fröland, and A. Glomstein: Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand. J. Infect. Dis. 23 (1991) 675-679
34. Rouger, P., P. Gane, and C. Salmon: Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies. Rev. Fr. Transfus. Immunohematol. 30 (1987) 699-708
35. Santagostino, E., P. M. Mannucci, A. Gringeri, A. Azzi, and M. Morfini: Eliminating parvovirus B19 from blood products. Lancet 343 (1994) 798
36. Sato, H., F. Takakura, E. Kojima, K. Fukada, K. Okochi, and Y. Maeda: Screening of blood donors for human parvovirus B19. Lancet 346 (1995) 1237-1238
37. Schwarz, T. F., M. Roggendorf und F. Deinhardt: Häufigkeit der Parvovirus-B19-Infektionen. Dtsch. Med. Wschr. 112 (1987) 1526-1531
38. Schwarz, T. F., M. Roggendorf, B. Hottenträger, W. Stolz, and H. Schwinn: Removal of parvovirus B19 from contaminated factor VIII during fractionation. J. Med. Virol. 35 (1991) 28-31
39. Schwarz, T. F., B. Hottenträger, and M. Roggendorf: Prevalence of antibodies to parvovirus B19 in selected groups of patients and healthy individuals. Zbl. Bakt. 276 (1992) 437-442
40. Tsuji, A., N. Uchida, S. Asamura, Y. Matsunaga, and S. Yamazaki: Aseptic meningitis with erythema infectiosum. Eur. J. Pediatr. 149 (1990) 449-450
41. Tsujimura, M., K. Matsusbita, H. Shiraki, H. Sato, K. Okochi, and Y. Maeda: Human parvovirus B19 infection in blood donors. Vox. Sang. 69 (1995) 206-212
42. Ueno, Y., H. Umadome, M. Shimodera, I. Kishimoto, K. Ikegaya, and T. Yamauchi: Human parvovirus B19 and arthritis. Lancet 341 (1993) 1280
43. Umene, K. and T. Nunoue: A new genome type of human parvovirus B19 present in sera of patients with encephalopathy. J. Gen. Virol. 76 (1995) 2645-2651
44. Watanabe, T., M. Satoh, and Y. Oda: Human parvovirus B19 encephalopathy. Arch. Dis. Child. 70 (1994) 71
45. White, D. G., P. P. Mortimer, D. R. Blake, A. D. Woolf, B. J. Cohen, and P. A. Bacon: Human parvovirus arthropathy. Lancet (1985) 419-421
46. Williams, M. D., B. J. Cohen, A. C. Beddall, K. J. Pasi, P. P. Mortimer, and F. G. H. Hill: Transmission of human parvovirus B19 by coagulation factor concentrates. Vox. Sang. 58 (1990) 177-181
47. Yoto, Y., T. Kudoh, K. Haseyama, N. Suzuki, T. Oda, T. Katoh, T. Takahashi, S. Sekiguchi, and S. Chiba: Incidence of human parvovirus B19 DNA detection in blood donors. Br. J. Haematol. 91 (1995) 1017-1018
48. Zakrzewska, K., A. Azzi, G. Patou, M. Morfini, D. Rafanelli, and J. R. Pattison: Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br. J. Haematol. 81 (1992) 407-412